A Phase 1 Dose Escalation Study of IPI-493
Infinity Pharmaceuticals, Inc.
Infinity Pharmaceuticals, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Biogen